[1]
NV, V., EK, N., Jones, J., Muttath, G., Nayanar, S. and NP, F. 2025. An Audit of Efficacy and Toxicity of Neoadjuvant Paclitaxel and Trastuzumab in HER- 2 Postive Locally Advanced Breast Cancer. Asian Pacific Journal of Cancer Care. 10, 2 (Apr. 2025), 387-391. DOI:https://doi.org/10.31557/apjcc.2025.10.2.387-391.